Merck & Co (MRK)
$92.10
0. (0.00%)
MRK Stock Quote Delayed 30 Minutes
7 Retirement Stocks for Steady Long-Term Income Growth
Investors looking for retirement stocks should look for companies with high growth and steady income and shun risky, unproven stocks.
11 Best Stocks to Buy for 2022
He found Apple at $1.49... Oracle at $0.51... Amazon at $46. Now, investing legend Louis Navellier is revealing his Top 11 Stocks for 2022 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
233.14B
PE Ratio
17.92
EPS
5.14
Volume (Avg. Vol.)
16
Day's Range
-
52-Week Range
$15.32 - $94.56
Dividend & Yield
$2.60 (2.82%)
MRK Stock Predictions, Articles, and Merck & Co News
3 Healthcare Stocks That Are Looking Even Healthier
These are the best healthcare stocks to invest in now. ISRG, MRK and TDOC can make great investments in the coming months.
3 Cash Cow Stocks to Buy for Stable Returns
From pharmaceuticals to energy, these are the best cash cow stocks to buy if you're looking to add stability to your portfolio.
Say Hello to 2022’s Dogs of the Dow: 10 Dividend Stocks to Watch
As investor appetite for high-growth stocks begins to decrease in the new year, dividend stocks will likely to gain traction in 2022.
ABSI Stock: 7 Things for Investors to Know About the Merck Deal That Has Absci Shares Flying Today
Absci (ABSI) stock is flying higher on Friday after announcing a major research collaboration agreement with Merck (MRK).
7 Stocks to Buy to Give Your Portfolio a Booster Shot
With the omicron variant of Covid-19 already touching down in the U.S., here are the stocks to buy to inoculate your portfolio.
Orally Administered Covid-19 Treatment Should Bolster Merck’s Value
MRK stock can have a place in just about any safety-focused biopharmaceutical portfolio as the stock offers dividends at a good value.
Merck Is a Dividend Play Ready to Get Back in Gear
Pfizer has been beating MRK stock in 2021, but that relative performance may reverse next year, with new drugs and acquisitions ahead.
Once-Cinderella Novavax Stock Could Be Poisoned by Merck’s Covid Pill
With a new oral antiviral drug by Merck potentially over the horizon, NVAX stock may be trading on borrowed time.
Novavax News: Why NVAX Stock Investors Have a Tough Pill to Swallow Today
Novavax (NVAX) stock is taking a beating on Friday as investors react to news about Merck (MRK) developing a COVID-19 treatment.
Merck News: The ‘Game-Changer’ Making MRK Stock the No. 1 Trending Ticker Today
Merck (MRK) stock is taking off on Friday thanks to positive news from a clinical trial for treating COVID-19 with molnupiravir.
